Latest California Healthline Stories
Restoring a Sense of Belonging: The Unsung Importance of Casual Relationships for Older Adults
Relationships with people you know only superficially can help develop a sense of belonging and provide motivation to engage in activities. Research has found that older adults who have a broad array of “weak” as well as “close” ties enjoy better physical and psychological well-being and live longer than people with less diverse social networks.
Women Say California Insurer Makes It Too Hard to Get Drug for Postpartum Depression
Brexanolone is a promising new treatment for postpartum depression. But one insurer’s requirement that women try four other drugs and electroconvulsive therapy before the infusion means it is out-of-reach for millions of women.
As Holdout Missouri Joins Nation in Monitoring Opioid Prescriptions, Experts Worry
Missouri is the last state to create a monitoring program to help spot the misuse of prescription drugs. But some public health experts warn that the nation’s programs are forcing people addicted to opioids to seek deadlier street options.
KHN’s ‘What the Health?’: Delta Changes the Covid Conversation
With covid cases on the upswing again around the country, partisan division remains over how to address the pandemic. Meanwhile, the Biden administration proposes bigger penalties for hospitals that fail to make their prices public as required. Stephanie Armour of The Wall Street Journal, Alice Miranda Ollstein of Politico and Tami Luhby of CNN join KHN’s Julie Rovner to discuss these issues and more. Also, for “extra credit,” the panelists suggest their favorite stories of the week they think you should read, too.
With a Diagnosis at Last, Black Women with ADHD Start Healing
Black women and girls with attention deficit hyperactivity disorder often remain undiagnosed because their symptoms are mischaracterized by the blinders of sexism and racism. Getting treatment and finding the right medication can be even more difficult because they aren’t taken seriously or, worse, they’re racially profiled while getting their medicines.
How ERs Fail Patients With Addiction: One Patient’s Tragic Death
Two intractable failings of the U.S. health care system — addiction treatment and medical costs — come to a head in the ER, where patients desperate for addiction treatment arrive, only to find the facility may not be equipped to deal with substance use or, if they are, treatment is prohibitively expensive.
Why We May Never Know Whether the $56,000-a-Year Alzheimer’s Drug Actually Works
It could take years for follow-up studies to prove Aduhelm slows the disease — or doesn’t. Meanwhile, its maker will profit.
Doctors Weigh Pros and Cons of Prescribing Hot-Button Alzheimer’s Drug
The potential benefits of Aduhelm are small, its effectiveness is not certain, and even the FDA Thursday shifted its guidance on who should get the drug. But physicians are dealing with an onslaught of interest from patients and their families, and figuring out which patients are best positioned to be helped by the drug will be difficult.
Doctores sopesan pros y contras de recetar la nueva droga para el Alzheimer
Mientras médicos y expertos en políticas de salud debaten los méritos de Aduhelm, el primer fármaco para el Alzheimer aprobado en 18 años, los pacientes simplemente quieren saber: “¿me ayudará?”.
A Family Wellness Check: California Invests in Treating Parents and Children Together
The state will be the first to offer comprehensive counseling services to parents during pediatric visits as part of Medicaid.